Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2012

Open Access 01-08-2012 | Research article

Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study

Authors: Mara A McAdams-DeMarco, Janet W Maynard, Josef Coresh, Alan N Baer

Published in: Arthritis Research & Therapy | Issue 4/2012

Login to get access

Abstract

Introduction

There is a growing prevalence of gout in the US and worldwide. Gout is a recognized risk factor for cardiovascular disease (CVD). It is unclear whether other risk factors for CVD are also associated with increased risk of gout. Anemia is one such CVD risk factor. No studies have evaluated the relationship between anemia and gout. We tested whether anemia was associated with incident gout independent of comorbid conditions in Atherosclerosis Risk in the Communities.

Methods

This population-based cohort recruited 15,792 individuals in 1987 to 1989 from four US communities and contained nine years of follow-up. Anemia was defined as hemoglobin <13.5 g/dL for men and <12 g/dL for women. Using a Cox Proportional Hazards model, we estimated the hazard ratio (HR) and confidence intervals (CI) of incident gout by baseline anemia, adjusted for confounders (sex, race, estimated glomerular filtration rate, body mass index and alcohol intake) and clinical factors (coronary heart disease, congestive heart failure, diabetes, hypertension, diuretic use and serum urate level).

Results

Among the 10,791 participants, 10% had anemia at baseline. There were 271 cases of incident gout. Patients with anemia had a two-fold increased risk of developing gout over nine years (HR = 2.01, 95% CI: 1.46, 2.76). Anemia was associated with incident gout independent of known gout risk factors, confounders and clinical risk factors (HR = 1.73, 95% CI: 1.24, 2.41). This association persisted after additionally adjusting for serum urate level (HR = 1.83, 95% CI: 1.30, 2.57).

Conclusion

We identified anemia as a novel risk factor for gout. Anemia was associated with an approximately two-fold increased risk of gout-independent kidney function and serum urate. These findings suggest that anemia is a risk factor for gout on par with other chronic conditions such as obesity and diabetes. The biological mechanism linking anemia to gout remains unclear.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008, 58: 26-35. 10.1002/art.23176.PubMedCentralCrossRefPubMed Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008, 58: 26-35. 10.1002/art.23176.PubMedCentralCrossRefPubMed
2.
go back to reference Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82: 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987, 82: 421-426. 10.1016/0002-9343(87)90441-4.CrossRefPubMed
3.
go back to reference Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H: Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010, 62: 1069-1076. 10.1002/art.27338.CrossRefPubMed Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H: Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010, 62: 1069-1076. 10.1002/art.27338.CrossRefPubMed
4.
go back to reference DeMarco McAdams MA, Maynard JW, Huizinga MM, Baer AN, Kottgen A, Gelber AC, Coresh J: Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res. 2011, 63: 1108-1114. 10.1002/acr.20479.CrossRef DeMarco McAdams MA, Maynard JW, Huizinga MM, Baer AN, Kottgen A, Gelber AC, Coresh J: Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res. 2011, 63: 1108-1114. 10.1002/acr.20479.CrossRef
5.
go back to reference Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005, 165: 742-748. 10.1001/archinte.165.7.742.CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005, 165: 742-748. 10.1001/archinte.165.7.742.CrossRefPubMed
6.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.CrossRefPubMed
7.
go back to reference Krishnan E, Baker JF, Furst DE, Schumacher HR: Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006, 54: 2688-2696. 10.1002/art.22014.CrossRefPubMed Krishnan E, Baker JF, Furst DE, Schumacher HR: Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006, 54: 2688-2696. 10.1002/art.22014.CrossRefPubMed
8.
go back to reference Choi HK, Curhan G: Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007, 116: 894-900. 10.1161/CIRCULATIONAHA.107.703389.CrossRefPubMed Choi HK, Curhan G: Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007, 116: 894-900. 10.1161/CIRCULATIONAHA.107.703389.CrossRefPubMed
9.
go back to reference Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH: Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008, 168: 1104-1110. 10.1001/archinte.168.10.1104.CrossRefPubMed Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH: Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008, 168: 1104-1110. 10.1001/archinte.168.10.1104.CrossRefPubMed
10.
go back to reference Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS: Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002, 40: 27-33. 10.1016/S0735-1097(02)01938-1.CrossRefPubMed Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS: Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002, 40: 27-33. 10.1016/S0735-1097(02)01938-1.CrossRefPubMed
11.
go back to reference Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006, 151: 492-500. 10.1016/j.ahj.2005.03.055.CrossRefPubMed Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2006, 151: 492-500. 10.1016/j.ahj.2005.03.055.CrossRefPubMed
12.
go back to reference Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47: 884-890. 10.1038/ki.1995.132.CrossRefPubMed Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47: 884-890. 10.1038/ki.1995.132.CrossRefPubMed
13.
go back to reference Penninx BW, Pahor M, Woodman RC, Guralnik JM: Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006, 61: 474-479. 10.1093/gerona/61.5.474.CrossRefPubMed Penninx BW, Pahor M, Woodman RC, Guralnik JM: Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006, 61: 474-479. 10.1093/gerona/61.5.474.CrossRefPubMed
14.
go back to reference Salive ME, Cornoni-Huntley J, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, Cohen HJ: Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc. 1992, 40: 489-496.CrossRefPubMed Salive ME, Cornoni-Huntley J, Guralnik JM, Phillips CL, Wallace RB, Ostfeld AM, Cohen HJ: Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J Am Geriatr Soc. 1992, 40: 489-496.CrossRefPubMed
15.
go back to reference Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Guala A, Lucca U: Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica. 2009, 94: 22-28. 10.3324/haematol.13449.PubMedCentralCrossRefPubMed Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A, Tallone MV, Detoma P, Giacomin A, Clerico M, Tempia P, Guala A, Lucca U: Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica. 2009, 94: 22-28. 10.3324/haematol.13449.PubMedCentralCrossRefPubMed
16.
go back to reference Nissenson AR, Goodnough LT, Dubois RW: Anemia: not just an innocent bystander?. Arch Intern Med. 2003, 163: 1400-1404. 10.1001/archinte.163.12.1400.CrossRefPubMed Nissenson AR, Goodnough LT, Dubois RW: Anemia: not just an innocent bystander?. Arch Intern Med. 2003, 163: 1400-1404. 10.1001/archinte.163.12.1400.CrossRefPubMed
17.
go back to reference Bergamini C, Cicoira M, Rossi A, Vassanelli C: Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Failure. 2009, 11: 444-452. 10.1093/eurjhf/hfp042.CrossRef Bergamini C, Cicoira M, Rossi A, Vassanelli C: Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure. Eur J Heart Failure. 2009, 11: 444-452. 10.1093/eurjhf/hfp042.CrossRef
18.
go back to reference The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989, 129: 687-702. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989, 129: 687-702.
19.
go back to reference Papp AC, Hatzakis H, Bracey A, Wu KK: ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989, 61: 15-19.PubMed Papp AC, Hatzakis H, Bracey A, Wu KK: ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989, 61: 15-19.PubMed
20.
go back to reference World Health Organization: Worldwide Prevalence of Anaemia 1993-2005. 2008, Geneva: World Health Organization World Health Organization: Worldwide Prevalence of Anaemia 1993-2005. 2008, Geneva: World Health Organization
21.
go back to reference McAdams MA, Maynard JW, Baer AN, Köttgen A, Clipp S, Coresh J, AC Gelber: Reliability and validity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease (CLUE II) and Atherosclerosis Risk in the Community (ARIC) Cohorts. J Rheum. 2011, 38: 135-141. 10.3899/jrheum.100418.PubMedCentralCrossRefPubMed McAdams MA, Maynard JW, Baer AN, Köttgen A, Clipp S, Coresh J, AC Gelber: Reliability and validity of the self-report of physician-diagnosed gout in the Campaign Against Cancer and Heart Disease (CLUE II) and Atherosclerosis Risk in the Community (ARIC) Cohorts. J Rheum. 2011, 38: 135-141. 10.3899/jrheum.100418.PubMedCentralCrossRefPubMed
22.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150: 604-612.PubMedCentralCrossRefPubMed Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150: 604-612.PubMedCentralCrossRefPubMed
23.
go back to reference Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994, 118: 496-500.PubMed Eckfeldt JH, Chambless LE, Shen YL: Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994, 118: 496-500.PubMed
24.
25.
go back to reference Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G: Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008, 67: 960-966.PubMedCentralCrossRefPubMed Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G: Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008, 67: 960-966.PubMedCentralCrossRefPubMed
26.
go back to reference Laughlin SK, Schroeder JC, Baird DD: New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010, 28: 204-217. 10.1055/s-0030-1251477.CrossRefPubMed Laughlin SK, Schroeder JC, Baird DD: New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010, 28: 204-217. 10.1055/s-0030-1251477.CrossRefPubMed
27.
go back to reference Cavusoglu E, Chopra V, Gupta A, Clark LT, Eng C, Marmur JD: Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol. 2006, 98: 580-584. 10.1016/j.amjcard.2006.03.031.CrossRefPubMed Cavusoglu E, Chopra V, Gupta A, Clark LT, Eng C, Marmur JD: Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol. 2006, 98: 580-584. 10.1016/j.amjcard.2006.03.031.CrossRefPubMed
28.
go back to reference Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E: Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005, 111: 2042-2049. 10.1161/01.CIR.0000162477.70955.5F.CrossRefPubMed Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E: Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005, 111: 2042-2049. 10.1161/01.CIR.0000162477.70955.5F.CrossRefPubMed
29.
go back to reference Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ, Sharaf BL, Reis SE, Smith KM, Johnson BD, Handberg E, Mankad D, Pepine CJ: Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol. 2004, 43: 2009-2014. 10.1016/j.jacc.2004.01.038.CrossRefPubMed Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ, Sharaf BL, Reis SE, Smith KM, Johnson BD, Handberg E, Mankad D, Pepine CJ: Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol. 2004, 43: 2009-2014. 10.1016/j.jacc.2004.01.038.CrossRefPubMed
30.
go back to reference Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E: Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis. 2010, 210: 575-580. 10.1016/j.atherosclerosis.2009.12.008.CrossRefPubMed Zoppini G, Targher G, Chonchol M, Negri C, Stoico V, Pichiri I, Lippi G, Muggeo M, Bonora E: Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. Atherosclerosis. 2010, 210: 575-580. 10.1016/j.atherosclerosis.2009.12.008.CrossRefPubMed
31.
go back to reference He SW, Wang LX: The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. Congest Heart Fail. 2009, 15: 123-130. 10.1111/j.1751-7133.2008.00030.x.CrossRefPubMed He SW, Wang LX: The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. Congest Heart Fail. 2009, 15: 123-130. 10.1111/j.1751-7133.2008.00030.x.CrossRefPubMed
32.
go back to reference Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003, 64: 610-615. 10.1046/j.1523-1755.2003.00109.x.CrossRefPubMed Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003, 64: 610-615. 10.1046/j.1523-1755.2003.00109.x.CrossRefPubMed
33.
go back to reference Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR: Impact of anemia on hospitalization and mortality in older adults. Blood. 2006, 107: 3841-3846. 10.1182/blood-2005-10-4308.CrossRefPubMed Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR: Impact of anemia on hospitalization and mortality in older adults. Blood. 2006, 107: 3841-3846. 10.1182/blood-2005-10-4308.CrossRefPubMed
34.
go back to reference Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999, 10: 610-619.PubMed Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999, 10: 610-619.PubMed
35.
go back to reference Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE: Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. 2006, 69: 560-564. 10.1038/sj.ki.5000105.CrossRefPubMed Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE: Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. 2006, 69: 560-564. 10.1038/sj.ki.5000105.CrossRefPubMed
36.
go back to reference Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ: Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005, 16: 3403-3410. 10.1681/ASN.2005030226.CrossRefPubMed Vlagopoulos PT, Tighiouart H, Weiner DE, Griffith J, Pettitt D, Salem DN, Levey AS, Sarnak MJ: Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005, 16: 3403-3410. 10.1681/ASN.2005030226.CrossRefPubMed
37.
go back to reference Oliva EN, Schey C, Hutchings AS: A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes. Am J Blood Res. 2011, 1: 160-166.PubMedCentralPubMed Oliva EN, Schey C, Hutchings AS: A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes. Am J Blood Res. 2011, 1: 160-166.PubMedCentralPubMed
38.
go back to reference Eckardt KU: Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant. 2005, 20 (Suppl 6): vi16-20.PubMed Eckardt KU: Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant. 2005, 20 (Suppl 6): vi16-20.PubMed
39.
go back to reference Yoo JH, Maeng HY, Sun YK, Kim YA, Park DW, Park TS, Lee ST, Choi JR: Oxidative status in iron-deficiency anemia. J Clin Lab Anal. 2009, 23: 319-323. 10.1002/jcla.20335.CrossRefPubMed Yoo JH, Maeng HY, Sun YK, Kim YA, Park DW, Park TS, Lee ST, Choi JR: Oxidative status in iron-deficiency anemia. J Clin Lab Anal. 2009, 23: 319-323. 10.1002/jcla.20335.CrossRefPubMed
40.
go back to reference Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P: Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986, 235: 747-754.PubMedCentralCrossRefPubMed Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P: Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986, 235: 747-754.PubMedCentralCrossRefPubMed
41.
go back to reference Ghio AJ, Kennedy TP, Rao G, Cooke CL, Miller MJ, Hoidal JR: Complexation of iron cation by sodium urate crystals and gouty inflammation. Arch Biochem Biophys. 1994, 313: 215-221. 10.1006/abbi.1994.1379.CrossRefPubMed Ghio AJ, Kennedy TP, Rao G, Cooke CL, Miller MJ, Hoidal JR: Complexation of iron cation by sodium urate crystals and gouty inflammation. Arch Biochem Biophys. 1994, 313: 215-221. 10.1006/abbi.1994.1379.CrossRefPubMed
42.
go back to reference Ghio AJ, Ford ES, Kennedy TP, Hoidal JR: The association between serum ferritin and uric acid in humans. Free Rad Res. 2005, 39: 337-342. 10.1080/10715760400026088.CrossRef Ghio AJ, Ford ES, Kennedy TP, Hoidal JR: The association between serum ferritin and uric acid in humans. Free Rad Res. 2005, 39: 337-342. 10.1080/10715760400026088.CrossRef
43.
go back to reference Facchini FS: Near-iron deficiency-induced remission of gouty arthritis. Rheumatology (Oxford). 2003, 42: 1550-1555. 10.1093/rheumatology/keg402.CrossRef Facchini FS: Near-iron deficiency-induced remission of gouty arthritis. Rheumatology (Oxford). 2003, 42: 1550-1555. 10.1093/rheumatology/keg402.CrossRef
44.
go back to reference Gutman AB, Yu TF: Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med. 1957, 23: 600-622. 10.1016/0002-9343(57)90231-0.CrossRefPubMed Gutman AB, Yu TF: Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med. 1957, 23: 600-622. 10.1016/0002-9343(57)90231-0.CrossRefPubMed
45.
go back to reference Robinson BE: Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc. 2006, 7: S3-6. 10.1016/j.jamda.2006.09.004. quiz S17-21CrossRefPubMed Robinson BE: Epidemiology of chronic kidney disease and anemia. J Am Med Dir Assoc. 2006, 7: S3-6. 10.1016/j.jamda.2006.09.004. quiz S17-21CrossRefPubMed
46.
go back to reference Zakai NA, McClure LA, Prineas R, Howard G, McClellan W, Holmes CE, Newsome BB, Warnock DG, Audhya P, Cushman M: Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol. 2009, 169: 355-364.PubMedCentralCrossRefPubMed Zakai NA, McClure LA, Prineas R, Howard G, McClellan W, Holmes CE, Newsome BB, Warnock DG, Audhya P, Cushman M: Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol. 2009, 169: 355-364.PubMedCentralCrossRefPubMed
47.
go back to reference Yip R, Dallman PR: The roles of inflammation and iron deficiency as causes of anemia. Am J Clin Nutr. 1988, 48: 1295-1300.PubMed Yip R, Dallman PR: The roles of inflammation and iron deficiency as causes of anemia. Am J Clin Nutr. 1988, 48: 1295-1300.PubMed
49.
go back to reference Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ: Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995, 38: 628-632. 10.1002/art.1780380508.CrossRefPubMed Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ: Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995, 38: 628-632. 10.1002/art.1780380508.CrossRefPubMed
Metadata
Title
Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study
Authors
Mara A McAdams-DeMarco
Janet W Maynard
Josef Coresh
Alan N Baer
Publication date
01-08-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4026

Other articles of this Issue 4/2012

Arthritis Research & Therapy 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.